Goto K, Ishige A, Sekiguchi K, Iizuka S, Sugimoto A, Yuzurihara M, Aburada M, Hosoya E, Kogure K
Tsumura Research Institute for Pharmacology, Ibaraki, Japan.
Brain Res. 1990 Nov 26;534(1-2):299-302. doi: 10.1016/0006-8993(90)90144-z.
The effect of cycloheximide, a protein synthesis inhibitor, on hippocampal selective neuronal death was morphologically studied in rats subjected to 10 min forebrain ischemia using a 4-vessel occlusion model. Neuronal damage in the hippocampal CA1 subfield 72 h after ischemic insult was dramatically decreased by the lasting inhibition of protein synthesis through consecutive administration of cycloheximide. Cycloheximide, which was administered once within the first 24 h of recirculation, showed protective action on ischemic cell necrosis and its most potent effect was observed when injected at 12 h of post-ischemia. After 36 h of recirculation, however, treatment with cycloheximide could no longer prevent cell death. The possibility is considered that hippocampal delayed neuronal death following transient ischemia is caused by abnormal protein(s).
采用四动脉闭塞模型,对遭受10分钟前脑缺血的大鼠,从形态学上研究了蛋白质合成抑制剂放线菌酮对海马选择性神经元死亡的影响。通过连续给予放线菌酮持续抑制蛋白质合成,缺血损伤72小时后海马CA1亚区的神经元损伤显著减少。在再灌注的最初24小时内单次给予放线菌酮,对缺血性细胞坏死具有保护作用,在缺血后12小时注射时观察到其最显著的效果。然而,再灌注36小时后,放线菌酮治疗不再能预防细胞死亡。由此认为,短暂性缺血后海马延迟性神经元死亡是由异常蛋白质引起的。